Searching journal content for prostate (as phrase) in full text.

Displaying results 1-10 of 875
For checked items
  1. ...prostate cancer, androgen deprivation is a key strategy in the management of metastatic prostate cancer. Androgens and androgen deprivation have profound effects on the immune system. Melissa Gamat & Douglas McNeel review this dynamic field and address the many unanswered challenges on how we best c ~~~
  2. ...prostate cancer and non-Hodgkin lymphoma (Yang et al. 2012, Jie et al. 2013, Yan et al. 2013, Cheng et al. 2015, Japp et al. 2015, Ji et al. 2015, Thommen et al. 2015, Cai et al. 2016, Xie et al. 2016). Preclinical models show conflicting results for the administration of TIM3-targeting monoclonal a ~~~
  3. ...prostate cancer immunotherapy 10.1530/ERC-17-0145 Melissa Gamat and Douglas G McNeel University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA Abstract Prostate cancer is the most common newly diagnosed malignancy in men, and the second most common cause of cancer-related death in the U ~~~
  4. ...prostate peptide vaccines The MKC1106-PP vaccine consists of a DNA vector, pPRA-PSM, encoding segments of two tumor antigens, PRAME and PSMA (Weber  et  al. 2011). Both PRAME and PSMA are expressed in a range of tumours (Silver  et  al. 1997, Conway et al. 2006, Lerut et al. 2015). The former facili ~~~
  5. ...prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, T344Thematic Review P Cukier et al. Immunotherapy-induced endocrinopathies DOI: 10.1530/ERC-17-0358 © 2018 Society for Endocrinology Printed in Great Britain Published by B ~~~
  6. ...prostate cancers (Kantoff et al. 2010). The field of DC vaccination is in its infancy, but this complex therapeutic strategy is being refined and improved each year (Butterfield 2013). Cost will continue to be a caveat for DC vaccines for the foreseeable future, but should not hinder the pursuit of ~~~
  7. ...prostate adenocarcinoma (Angelsen 313 et al. 1997). By contrast, there are some tumours showing CgA elevation where the presence of 314 histological neuroendocrine differentiation has not been reported, such as primary hepatocellular 315 cancer (Spadaro et al. 2005) and breast cancer (Giovanella et ~~~
  8. ...prostate cancer by activating canonical Wnt/beta-catenin signaling. Cancer Letters 402 166–176. (doi:10.1016/j.canlet.2017.05.029) Lu C, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, et al. 2013 Induction of sarcomas by mutant IDH2. Genes and Development 2 ~~~
  9. ...prostate biopsy based on serum androgen 1 level 2 1Takeshi Ujike, 1,2Motohide Uemura*, 1Atsunari Kawashima, 3 1Akira Nagahara, 1Kazutoshi Fujita, 1Yasushi Miyagawa 4 and 1Norio Nonomura 5 6 1Department of Urology, 7 Osaka University Graduate School of Medicine, 8 2-2 Yamadaoka, 9 Suita Osaka 565-087 ~~~
  10. ...prostate cancer 2 Zhu Wang 1,3,# , Dinglan Wu 4,1,# , Chi-Fai Ng , Jeremy Yuen-Chun Teoh , Shan Yu , Yuliang 3 Wang 1,* and Franky L. Chan 1,* 4 School of Biomedical Sciences and Department of Surgery, Faculty of Medicine, the 5 Chinese University of Hong Kong, Hong Kong, China 6 Department of Urolo ~~~
For checked items